In our results indicated the combination group presented significantly higher expression of granzyme-B and apoptotic proteins (BAX and cleaved-caspase-3) in CT-26 or B16-F10 tumor tissues compared to hIL15-ABD or anti-PD-L1 therapy (Figure 5I–K and Figure 4N–P). This evidence concerns the gene GZMB and neoplasm.